August 15, 2012
By 2016, Inside Oncology’s new market intelligence report: Academic Cancer Centers (NCCC): Trends Impacting Key Account Management is predicting that
(more)
January 26, 2011
For those of you who have been following this blog you will recall that I have spent a lot of time discussing cancer drug costs and the lack of
(more)
October 14, 2010
While winter is approaching and the hockey season has already begun for sports fans, another kind of hockey related event is approaching
(more)
August 24, 2010
The question is no longer whether or not Medicare will do it but when and how. The initiation of a National Coverage Decision
(more)
July 29, 2010
On Wednesday the 28th Allos announced the results of their randomized phase 2 study comparing Folotyn
(more)
July 12, 2010
On July 1st CMS announced that Dendreon’s Provenge® will undergo a National Coverage Determination (NCD).
(more)
June 29, 2010
This past ASCO in Chicago was something like the 18th or 19th one that I have attended, and it has grown from a few thousand physicians to
(more)